Delivery Order SPE2DB20D1109-SPE2DB25FP48X
Award Date 7/30/25
Potential Completion Date 8/20/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $100,573.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the awardee's corporate headquarters in Conshohocken, Pennsylvania. XEOMIN is a botulinum toxin product used in medical applications, and this order supports the federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,117.48 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN on July 28, 2025, with an ultimate completion date of August 18, 2025. This firm fixed-price contract represents a non-competitive set-aside and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX),...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $33,524.40 for XEOMIN 100 unit vials under a firm fixed price contract with the Medical Supply Chain, a component of the Defense Logistics Agency. The award, issued on August 25, 2025, is scheduled for completion by September 16, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a competitive award with no set-aside designation and is issued as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,793.70 to AmerisourceBergen Drug Corp for 100-unit vials of XEOMIN, a botulinum toxin product used for therapeutic and cosmetic medical applications. This firm fixed price delivery order, awarded on August 28, 2025, is set to be completed by September 19, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania location. As a non-set-aside competitive award, this delivery order was issued under...
- The Defense Logistics Agency awarded a $3,352.44 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of XEOMIN, a botulinum toxin-based therapeutic product commonly used for medical and cosmetic purposes. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for...
- The Defense Logistics Agency awarded a delivery order valued at $7,263.62 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with an ultimate completion date of August 13, 2025. This firm fixed price delivery order, issued on July 23, 2025, was competitively awarded without a set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Xeomin 50 unit vials valued at $10,941.84. This competitively awarded, non-set-aside contract is structured as a firm fixed price delivery order with a completion date of September 10, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order falls under the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,704.88 to AmerisourceBergen Drug Corp for XEOMIN 100 Unit Vials, with a completion date of September 30, 2025. The contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded on September 9, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award is issued as a child contract under...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,215.76 to AmerisourceBergen Drug Corp for XEOMIN 50U (botulinum toxin Type A), a pharmaceutical product used in medical and therapeutic applications. This firm fixed price delivery order, issued on August 29, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive award issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical....
- The Defense Logistics Agency awarded a delivery order valued at $3,039.40 to AmerisourceBergen Drug Corp for 50-unit vials of XEOMIN, a botulinum toxin product used for medical and therapeutic purposes. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 28, 2025, and will be performed at AmerisourceBergen's corporate facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation. This delivery order is issued under...